Literature DB >> 20608972

BRCA1 16 years later: nuclear import and export processes.

Marilyn E Thompson1.   

Abstract

Over the past several years, the importance of regulated nuclear transport processes for tumor suppressors has become evident. Proteins with a molecular mass greater than 40 kDa can enter the nucleus only by active transport across the nuclear membrane. The most common pathway by which this occurs is via the importin alpha/beta pathway, whereby the cargo protein binds importin alpha. This heterodimer binds importin beta and the heterotrimer passes through nuclear pores at the expense of GTP. Breast cancer susceptibility gene 1 (BRCA1) is one such protein. As a mediator of transcription and DNA repair, two exclusively nuclear functions, BRCA1, at 220 kDa, can enter the nucleus only via active transport mechanisms. In addition to the classical importin alpha/beta pathway, BRCA1 can also enter the nucleus in a piggyback mechanism with BRCA1-associated RING domain protein 1 (BARD1). The interaction between BRCA1 and BARD1 is also important in the retention of BRCA1 in the nucleus. This is important because BRCA1 also undergoes active nuclear export. BRCA1 is also involved in apoptotic processes. Whether this occurs within the nucleus or cytoplasm is still unclear; thus, the consequences of BRCA1 nuclear export have not been clearly elucidated. This review will discuss the literature regarding the subcellular localization of BRCA1, with particular emphasis on its nuclear import and export processes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20608972     DOI: 10.1111/j.1742-4658.2010.07733.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  28 in total

1.  Role of the nuclear receptor coactivator AIB1-Delta4 splice variant in the control of gene transcription.

Authors:  Christopher D Chien; Alexander Kirilyuk; Jordan V Li; Wentao Zhang; Tyler Lahusen; Marcel O Schmidt; Annabell S Oh; Anton Wellstein; Anna T Riegel
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

2.  Nucleoporin NUP153 guards genome integrity by promoting nuclear import of 53BP1.

Authors:  P Moudry; C Lukas; L Macurek; B Neumann; J-K Heriche; R Pepperkok; J Ellenberg; Z Hodny; J Lukas; J Bartek
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

Review 3.  Design Principles Involving Protein Disorder Facilitate Specific Substrate Selection and Degradation by the Ubiquitin-Proteasome System.

Authors:  Mainak Guharoy; Pallab Bhowmick; Peter Tompa
Journal:  J Biol Chem       Date:  2016-02-05       Impact factor: 5.157

4.  Hypoxia elicits broad and systematic changes in protein subcellular localization.

Authors:  Robert Michael Henke; Ranita Ghosh Dastidar; Ajit Shah; Daniela Cadinu; Xiao Yao; Jagmohan Hooda; Li Zhang
Journal:  Am J Physiol Cell Physiol       Date:  2011-07-13       Impact factor: 4.249

5.  Induced Cre-mediated knockdown of Brca1 in skeletal muscle reduces mitochondrial respiration and prevents glucose intolerance in adult mice on a high-fat diet.

Authors:  Kathryn C Jackson; Michael D Tarpey; Ana P Valencia; Melissa R Iñigo; Stephen J Pratt; Daniel J Patteson; Joseph M McClung; Richard M Lovering; David M Thomson; Espen E Spangenburg
Journal:  FASEB J       Date:  2018-01-26       Impact factor: 5.191

6.  Ubc9 mediates nuclear localization and growth suppression of BRCA1 and BRCA1a proteins.

Authors:  Yunlong Qin; Jingyao Xu; Kartik Aysola; Nurjahan Begum; Vaishali Reddy; Yuli Chai; William E Grizzle; Edward E Partridge; E Shyam P Reddy; Veena N Rao
Journal:  J Cell Physiol       Date:  2011-12       Impact factor: 6.384

7.  Exploiting the P-1 pocket of BRCT domains toward a structure guided inhibitor design.

Authors:  Ziyan Yuan; Eric A Kumar; Stephen J Campbell; Nicholas Y Palermo; Smitha Kizhake; J N Mark Glover; Amarnath Natarajan
Journal:  ACS Med Chem Lett       Date:  2011-10-13       Impact factor: 4.345

8.  Inhibition of Stat5a/b Enhances Proteasomal Degradation of Androgen Receptor Liganded by Antiandrogens in Prostate Cancer.

Authors:  David T Hoang; Lei Gu; Zhiyong Liao; Feng Shen; Pooja G Talati; Mateusz Koptyra; Shyh-Han Tan; Elyse Ellsworth; Shilpa Gupta; Heather Montie; Ayush Dagvadorj; Saija Savolainen; Benjamin Leiby; Tuomas Mirtti; Diane E Merry; Marja T Nevalainen
Journal:  Mol Cancer Ther       Date:  2014-12-31       Impact factor: 6.261

9.  Targeting BRCA1 localization to augment breast tumor sensitivity to poly(ADP-Ribose) polymerase inhibition.

Authors:  Eddy S Yang; Somaira Nowsheen; Mohammad A Rahman; Rebecca S Cook; Fen Xia
Journal:  Cancer Res       Date:  2012-09-07       Impact factor: 12.701

10.  Systematic nucleo-cytoplasmic trafficking of proteins following exposure of MCF7 breast cancer cells to estradiol.

Authors:  Gabriella Pinto; Abdulrab Ahmed M Alhaiek; Sepan Amadi; Amal T Qattan; Mark Crawford; Marko Radulovic; Jasminka Godovac-Zimmermann
Journal:  J Proteome Res       Date:  2014-01-24       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.